Doxofylline Impurity A

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB04861
Synonyms	1-((1,3-dioxolan-2-yl)methyl)-4-(1,3-dimethylureido)-1H-imidazole-5-carboxylic acid
Molecular Weight	284.27
Molecular Formula	C11H16N4O5

What is the molecular weight of Doxofylline Impurity A?

The molecular weight of Doxofylline Impurity A is 284.27.

What is the molecular formula of Doxofylline Impurity A?

The molecular formula of Doxofylline Impurity A is C11H16N4O5.

What are some synonyms for Doxofylline Impurity A?

One synonym for Doxofylline Impurity A is 1-((1,3-dioxolan-2-yl)methyl)-4-(1,3-dimethylureido)-1H-imidazole-5-carboxylic acid.

What is the chemical structure of Doxofylline Impurity A?

The chemical structure of Doxofylline Impurity A is 1-((1,3-dioxolan-2-yl)methyl)-4-(1,3-dimethylureido)-1H-imidazole-5-carboxylic acid.

What is the significance of Doxofylline Impurity A in pharmaceuticals?

Doxofylline Impurity A is an impurity that is present in the pharmaceutical compound Doxofylline, which is used to treat respiratory disorders.

How is Doxofylline Impurity A formed during the production process?

Doxofylline Impurity A is formed as a byproduct during the synthesis of Doxofylline.

What are the potential implications of Doxofylline Impurity A in pharmaceutical formulations?

The presence of Doxofylline Impurity A in pharmaceutical formulations may affect the effectiveness and safety of the medication.

How is the purity of Doxofylline Impurity A typically determined in pharmaceutical quality control?

The purity of Doxofylline Impurity A is typically determined using analytical techniques such as high-performance liquid chromatography (HPLC).

What are some methods for minimizing the presence of Doxofylline Impurity A in pharmaceutical products?

Some methods for minimizing the presence of Doxofylline Impurity A in pharmaceutical products include optimizing the synthesis process and implementing rigorous quality control measures.

Are there regulations or guidelines regarding the acceptable levels of Doxofylline Impurity A in pharmaceutical formulations?

Yes, regulatory authorities such as the FDA may have guidelines or limits on the acceptable levels of impurities, including Doxofylline Impurity A, in pharmaceutical formulations.

* Products or Services Interested: Doxofylline Impurity A ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry